| 38061411 | Simvastatin restores pulmonary endothelial function in the setting of pulmonary over-circulation. | Nitric Oxide | 2024 |
| 36345832 | The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension. | Hypertension | 2023 |
| 37659679 | Endothelin-1 acutely increases nitric oxide production via the calcineurin mediated dephosphorylation of Caveolin-1. | Nitric Oxide | 2023 |
| 37392518 | Metabolic reprogramming, oxidative stress, and pulmonary hypertension. | Redox Biol | 2023 |
| 37298092 | Circadian-Coupled Genes Expression and Regulation in HIV-Associated Chronic Obstructive Pulmonary Disease (COPD) and Lung Comorbidities. | Int J Mol Sci | 2023 |
| 37091123 | Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome. | Pulm Circ | 2023 |
| 36913491 | SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics. | Am J Respir Crit Care Med | 2023 |
| 36894537 | SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy. | Signal Transduct Target Ther | 2023 |
| 36371548 | Inflammation and vascular remodeling in COVID-19 hearts. | Angiogenesis | 2023 |
| 35203550 | Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension. | Biomedicines | 2022 |
| 35370763 | Editorial: Pathophysiology and Pathogenic Mechanisms of Pulmonary Vascular Disease. | Front Physiol | 2022 |
| 35575096 | Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. | J Clin Invest | 2022 |
| 35422958 | SOX18-associated gene signature predicts sepsis outcome. | Am J Transl Res | 2022 |
| 36620216 | Loss of SOX18/CLAUDIN5 disrupts the pulmonary endothelial barrier in ventilator-induced lung injury. | Front Physiol | 2022 |
| 36398242 | NAMPT-associated gene signature in the prediction of severe sepsis. | Am J Transl Res | 2022 |
| 36206625 | The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling. | EBioMedicine | 2022 |
| 35991176 | NF-κB-dependent repression of Sox18 transcription factor requires the epigenetic regulators histone deacetylases 1 and 2 in acute lung injury. | Front Physiol | 2022 |
| 33248422 | RAC1 nitration at Y<sup>32</sup> IS involved in the endothelial barrier disruption associated with lipopolysaccharide-mediated acute lung injury. | Redox Biol | 2021 |
| 33719747 | Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, <i>in vitro</i> 2D/3D human lung cell cultures, and <i>in vivo</i> efficacy. | Ther Adv Respir Dis | 2021 |
| 33549110 | Identification of S1PR3 gene signature involved in survival of sepsis patients. | BMC Med Genomics | 2021 |
| 33788198 | Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension. | Adv Exp Med Biol | 2021 |
| 33788186 | Anti-inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials. | Adv Exp Med Biol | 2021 |
| 33578126 | The mitochondrial redistribution of eNOS is involved in lipopolysaccharide induced inflammasome activation during acute lung injury. | Redox Biol | 2021 |
| 34858182 | Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension. | Front Pharmacol | 2021 |
| 34959469 | Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery. | Pharmaceutics | 2021 |
| 34669509 | Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension. | Am J Physiol Cell Physiol | 2021 |
| 34422822 | Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension. | Front Cell Dev Biol | 2021 |
| 34568460 | Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension. | Front Cardiovasc Med | 2021 |
| 34252457 | Nitration of protein kinase G-Iα modulates cyclic nucleotide crosstalk via phosphodiesterase 3A: Implications for acute lung injury. | J Biol Chem | 2021 |
| 33221570 | Activation of the mechanosensitive Ca<sup>2+</sup> channel TRPV4 induces endothelial barrier permeability via the disruption of mitochondrial bioenergetics. | Redox Biol | 2021 |
| 33338599 | Arginine recycling in endothelial cells is regulated BY HSP90 and the ubiquitin proteasome system. | Nitric Oxide | 2021 |
| 32489641 | Mechanical forces alter endothelin-1 signaling: comparative ovine models of congenital heart disease. | Pulm Circ | 2020 |
| 33556627 | Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH. | Pulm Pharmacol Ther | 2020 |
| 31976548 | Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension. | Br J Pharmacol | 2020 |
| 33200330 | Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers. | AAPS J | 2020 |
| 33137515 | Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery. | Pulm Pharmacol Ther | 2020 |
| 32818797 | Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. | Redox Biol | 2020 |
| 32554303 | TGF-β1 attenuates mitochondrial bioenergetics in pulmonary arterial endothelial cells via the disruption of carnitine homeostasis. | Redox Biol | 2020 |
| 30358436 | Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. | Am J Physiol Lung Cell Mol Physiol | 2019 |
| 31126972 | Bif-1 Interacts with Prohibitin-2 to Regulate Mitochondrial Inner Membrane during Cell Stress and Apoptosis. | J Am Soc Nephrol | 2019 |
| 31032737 | EXPRESS: Surfing the Right Ventricular Pressure Waveform: Methods to assess Global, Systolic and Diastolic RV Function from a Clinical Right Heart Catheterization. | Pulm Circ | 2019 |
| 31169025 | Compartmentalization of Redox-Regulated Signaling in the Pulmonary Circulation. | Antioxid Redox Signal | 2019 |
| 31105595 | Pulmonary Endothelial Mechanical Sensing and Signaling, a Story of Focal Adhesions and Integrins in Ventilator Induced Lung Injury. | Front Physiol | 2019 |
| 30623676 | Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease. | Antioxid Redox Signal | 2019 |
| 30620615 | Ovine Models of Congenital Heart Disease and the Consequences of Hemodynamic Alterations for Pulmonary Artery Remodeling. | Am J Respir Cell Mol Biol | 2019 |
| 29115856 | LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18. | Am J Respir Cell Mol Biol | 2018 |
| 30190422 | Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. | Mol Cancer Ther | 2018 |
| 30623134 | Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension. | JACC Basic Transl Sci | 2018 |
| 29421689 | Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension. | Am J Med | 2018 |
| 29074488 | Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. | Am J Physiol Lung Cell Mol Physiol | 2018 |